Lumito AB (NGM:LUMITO) Enterprise Value: kr4.24 Mil (As of Jul. 28, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LUMITO Lumito AB NGM:LUMITO
18 GF Score
Price kr2.37
! 2 Warning Signs
View Full Analysis

What is Lumito AB Enterprise Value?

Lumito AB NGM:LUMITO +10.00% 18 Enterprise Value is kr4.24 Mil as of Jul. 28, 2026. GuruFocus rates NGM:LUMITO with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lumito AB's Enterprise Value is kr4.24 Mil. Lumito AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-40.60 Mil. Therefore, Lumito AB's EV-to-EBIT ratio for today is -0.10.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Lumito AB's Enterprise Value is kr4.24 Mil. Lumito AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-21.17 Mil. Therefore, Lumito AB's EV-to-EBITDA ratio for today is -0.20.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Lumito AB's Enterprise Value is kr4.24 Mil. Lumito AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.08 Mil. Therefore, Lumito AB's EV-to-Revenue ratio for today is 54.35.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Lumito AB's Enterprise Value is kr4.24 Mil. Lumito AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was kr-25.69 Mil. Therefore, Lumito AB's EV-to-OCF ratio for today is -0.17.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Lumito AB's Enterprise Value is kr4.24 Mil. Lumito AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-25.85 Mil. Therefore, Lumito AB's EV-to-FCF ratio for today is -0.16.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Lumito AB  (NGM:LUMITO) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Lumito AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.239/-40.599
=-0.10

Lumito AB's current Enterprise Value is kr4.24 Mil.
Lumito AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-40.60 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Lumito AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4.239/-21.171
=-0.20

Lumito AB's current Enterprise Value is kr4.24 Mil.
Lumito AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-21.17 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Lumito AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.239/0.078
=54.35

Lumito AB's current Enterprise Value is kr4.24 Mil.
Lumito AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.08 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Lumito AB's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=4.239/-25.689
=-0.17

Lumito AB's current Enterprise Value is kr4.24 Mil.
Lumito AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-25.69 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Lumito AB's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4.239/-25.848
=-0.16

Lumito AB's current Enterprise Value is kr4.24 Mil.
Lumito AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-25.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumito AB Enterprise Value Related Terms


Lumito AB Enterprise Value Historical Data

* Premium members only.

The historical data trend for Lumito AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumito AB Enterprise Value Chart

Lumito AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only 73.69 251.23 307.51 132.88 8.31

Lumito AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.59 158.72 36.32 8.31 5.46

NGM:LUMITO vs TMO, DHR, IDXX: Enterprise Value Comparison

For the Diagnostics & Research subindustry, Lumito AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumito AB Enterprise Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumito AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Lumito AB's Enterprise Value falls into.


NGM:LUMITO
18GF Score
Lumito AB NGM:LUMITO
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumito AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Lumito AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Lumito AB's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of kr4.24 Mil mean?
Lumito AB (NGM:LUMITO) has a Enterprise Value of kr4.24 Mil as of Jul. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Lumito AB and its competitors.
Is Lumito AB's Enterprise Value too high?
Lumito AB's current Enterprise Value is kr4.24 Mil. Overall, Lumito AB has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Lumito AB's Enterprise Value compare to TMO and DHR?
Lumito AB's Enterprise Value of kr4.24 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Lumito AB and its competitors. Lumito AB's current Enterprise Value is kr4.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumito AB stock overvalued right now?
Lumito AB (NGM:LUMITO) has a current Enterprise Value of kr4.24 Mil. The current Enterprise Value is kr4.24 Mil. Lumito AB's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Lumito AB (NGM:LUMITO), the current Enterprise Value is kr4.24 Mil as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumito AB Business Description

Address Scheelevagen 19, Lund, SWE, 223 63
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed the next-generation tissue analysis system, based on upconverting nanoparticles (UCNPs). Lumito SCIZYS is a cutting-edge, high-sensitivity system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company holds a broad patent portfolio of three patent families. Lumito's solution enables quantitative and objective assessment of tissue samples, addressing a multitude of challenges in drug development and academic research.
18GF Score

Get the complete analysis for NGM:LUMITO

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.37
Price